{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:33:25Z","timestamp":1793745205513,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016290","name":"Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["OG-0223"],"award-info":[{"award-number":["OG-0223"]}],"id":[{"id":"10.13039\/501100016290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04223-w","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:59:25Z","timestamp":1754542765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The in vitro evaluation of synergistic effects of ciprofloxacin and berberine hydrochloride against Pseudomonas aeruginosa"],"prefix":"10.1186","volume":"25","author":[{"given":"Anis","family":"Zeraatpisheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maniya","family":"Arshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massomeh","family":"Zahmatkeshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh Nezhad","family":"Dehbashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentolhoda","family":"Amanzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farshadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"6","key":"4223_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/microorganisms7060180","volume":"7","author":"SA Kraemer","year":"2019","unstructured":"Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: from microbial ecology to public policy. Microorganisms. 2019;7(6):180.","journal-title":"Microorganisms"},{"issue":"3","key":"4223_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/apm.13010","volume":"128","author":"S Crone","year":"2020","unstructured":"Crone S, Vives-Fl\u00f3rez M, Kvich L, Saunders AM, Malone M, Nicolaisen MH, et al. The environmental occurrence of Pseudomonas aeruginosa. Apmis. 2020;128(3):220\u201331.","journal-title":"Apmis"},{"issue":"5","key":"4223_CR3","doi-asserted-by":"publisher","first-page":"fiw042","DOI":"10.1093\/femsec\/fiw042","volume":"92","author":"P Olga","year":"2016","unstructured":"Olga P, Apostolos V, Alexis G, George V, Athena M. Antibiotic resistance profiles of Pseudomonas aeruginosa isolated from various Greek aquatic environments. FEMS Microbiol Ecol. 2016;92(5):fiw042.","journal-title":"FEMS Microbiol Ecol"},{"issue":"9","key":"4223_CR4","doi-asserted-by":"publisher","first-page":"14689","DOI":"10.1002\/jcp.28225","volume":"234","author":"JY Sharahi","year":"2019","unstructured":"Sharahi JY, Azimi T, Shariati A, Safari H, Tehrani MK, Hashemi A. Advanced strategies for combating bacterial biofilms. J Cell Physiol. 2019;234(9):14689\u2013708.","journal-title":"J Cell Physiol"},{"issue":"2","key":"4223_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.52547\/JCBioR.2.2.56","volume":"2","author":"A Mohsenzadeh","year":"2021","unstructured":"Mohsenzadeh A, Fazel A, Bavari S, Borji S, Pourasghar S, Azimi T, et al. Detecting of biofilm formation in the clinical isolates of Pseudomonas aeruginosa and Escherichia coli: an evaluation of different screening methods. J Curr Biomedical Rep. 2021;2(2):56\u201361.","journal-title":"J Curr Biomedical Rep"},{"issue":"24","key":"4223_CR6","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.3390\/molecules24244560","volume":"24","author":"S-C Park","year":"2019","unstructured":"Park S-C, Lee M-Y, Kim J-Y, Kim H, Jung M, Shin M-K, et al. Anti-biofilm effects of synthetic antimicrobial peptides against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus planktonic cells and biofilm. Molecules. 2019;24(24):4560.","journal-title":"Molecules"},{"issue":"4","key":"4223_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/AAC.48.4.1168-1174.2004","volume":"48","author":"N Bagge","year":"2004","unstructured":"Bagge N, Hentzer M, Andersen JB, Ciofu O, Givskov M, H\u00f8iby N. Dynamics and Spatial distribution of \u03b2-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2004;48(4):1168\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"4223_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00134-012-2808-5","volume":"39","author":"I Martin-Loeches","year":"2013","unstructured":"Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med. 2013;39:672\u201381.","journal-title":"Intensive Care Med"},{"issue":"7","key":"4223_CR9","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1128\/AAC.45.7.1964-1971.2001","volume":"45","author":"K Okamoto","year":"2001","unstructured":"Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to Penem antibiotics: Penem resistance mechanisms and their interplay. Antimicrob Agents Chemother. 2001;45(7):1964\u201371.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7441","key":"4223_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","volume":"328","author":"M Paul","year":"2004","unstructured":"Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. \u03b2 lactam monotherapy versus \u03b2 lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ. 2004;328(7441):668.","journal-title":"BMJ"},{"issue":"2","key":"4223_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","volume":"49","author":"K Poole","year":"2005","unstructured":"Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49(2):479\u201387.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4223_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00000542-200610000-00016","volume":"105","author":"J Rello","year":"2006","unstructured":"Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, et al. Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology. 2006;105(4):709\u201314.","journal-title":"Anesthesiology"},{"issue":"10","key":"4223_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/1469-0691.12089","volume":"19","author":"J Horcajada","year":"2013","unstructured":"Horcajada J, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect. 2013;19(10):962\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"4223_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/jmm.0.000873","volume":"68","author":"A Rehman","year":"2019","unstructured":"Rehman A, Patrick WM, Lamont IL. Mechanisms of Ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol. 2019;68(1):1\u201310.","journal-title":"J Med Microbiol"},{"issue":"11","key":"4223_CR15","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1021\/pr9005074","volume":"8","author":"Y Xu","year":"2009","unstructured":"Xu Y, Wang Y, Yan L, Liang R-M, Dai B-D, Tang R-J, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and Berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res. 2009;8(11):5296\u2013304.","journal-title":"J Proteome Res"},{"issue":"4","key":"4223_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1089\/jmf.2005.8.454","volume":"8","author":"H-H Yu","year":"2005","unstructured":"Yu H-H, Kim K-J, Cha J-D, Kim H-K, Lee Y-E, Choi N-Y, et al. Antimicrobial activity of Berberine alone and in combination with ampicillin or Oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food. 2005;8(4):454\u201361.","journal-title":"J Med Food"},{"issue":"4","key":"4223_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.030540597","volume":"97","author":"FR Stermitz","year":"2000","unstructured":"Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of Berberine potentiated by 5\u2032-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci. 2000;97(4):1433\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"4223_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2166\/wst.2010.857","volume":"61","author":"S Zhang","year":"2010","unstructured":"Zhang S, Zhang B, Xing K, Zhang X, Tian X, Dai W. Inhibitory effects of golden thread (Coptis chinensis) and Berberine on Microcystis aeruginosa. Water Sci Technol. 2010;61(3):763\u20139.","journal-title":"Water Sci Technol"},{"issue":"2","key":"4223_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1086\/313677","volume":"30","author":"DC Hooper","year":"2000","unstructured":"Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis. 2000;30(2):243\u201354.","journal-title":"Clin Infect Dis"},{"issue":"Supplement2","key":"4223_CR20","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1086\/428051","volume":"41","author":"VT Andriole","year":"2005","unstructured":"Andriole VT. The quinolones: past, present, and future. Clin Infect Dis. 2005;41(Supplement2):S113\u20139.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4223_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.3390\/ijms17101688","volume":"17","author":"SN K\u0142odzi\u0144ska","year":"2016","unstructured":"K\u0142odzi\u0144ska SN, Priemel PA, Rades T, M\u00f8rck Nielsen H. Inhalable antimicrobials for treatment of bacterial biofilm-associated sinusitis in cystic fibrosis patients: challenges and drug delivery approaches. Int J Mol Sci. 2016;17(10):1688.","journal-title":"Int J Mol Sci"},{"key":"4223_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10096-017-2907-x","volume":"36","author":"M Paulsson","year":"2017","unstructured":"Paulsson M, Granrot A, Ahl J, Tham J, Resman F, Riesbeck K, et al. Antimicrobial combination treatment including Ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36:1187\u201396.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4223_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/clinids\/21.1.194","volume":"21","author":"R Raz","year":"1995","unstructured":"Raz R, Miron D. Oral Ciprofloxacin for treatment of infection following nail puncture wounds of the foot. Clin Infect Dis. 1995;21(1):194\u20135.","journal-title":"Clin Infect Dis"},{"key":"4223_CR24","doi-asserted-by":"crossref","unstructured":"M\u00f6sges R, Nematian-Samani M, Eichel A. Treatment of acute otitis externa with Ciprofloxacin otic 0.2% antibiotic ear solution. Ther Clin Risk Manag. 2011:325\u201336.","DOI":"10.2147\/TCRM.S6769"},{"key":"4223_CR25","doi-asserted-by":"crossref","unstructured":"Remmington T, Jahnke N, Harkensee C. Oral anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Reviews. 2013(10).","DOI":"10.1002\/14651858.CD005405.pub3"},{"issue":"9","key":"4223_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/thorax.58.9.794","volume":"58","author":"T Pitt","year":"2003","unstructured":"Pitt T, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003;58(9):794\u20136.","journal-title":"Thorax"},{"issue":"1","key":"4223_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/jac\/dkm129","volume":"60","author":"D Landman","year":"2007","unstructured":"Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in brooklyn, NY. J Antimicrob Chemother. 2007;60(1):78\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"4223_CR28","unstructured":"Rouhi S, Ramazanzadeh R, Nouri B. Genotyping, pandrug resistance, extensively drug-resistant, and multi drug-resistance detection of pseudomonas aeruginosa isolated from patients in the West of Iran. Crescent J Med Biol Sci. 2019;6(2)."},{"issue":"1","key":"4223_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2006.11.007","volume":"58","author":"M Motoshima","year":"2007","unstructured":"Motoshima M, Yanagihara K, Fukushima K, Matsuda J, Sugahara K, Hirakata Y, et al. Rapid and accurate detection of Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis targeting GyrB gene. Diagn Microbiol Infect Dis. 2007;58(1):53\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"4223_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/mps1030024","volume":"1","author":"BC Agaras","year":"2018","unstructured":"Agaras BC, Valverde C. A novel oligonucleotide pair for genotyping members of the Pseudomonas genus by single-round PCR amplification of the GyrB gene. Methods Protocols. 2018;1(3):24.","journal-title":"Methods Protocols"},{"issue":"5","key":"4223_CR31","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s11033-022-07225-3","volume":"49","author":"R Heidari","year":"2022","unstructured":"Heidari R, Farajzadeh Sheikh A, Hashemzadeh M, Farshadzadeh Z, Salmanzadeh S, Saki M. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in Southwestern Iran. Mol Biol Rep. 2022;49(5):3811\u201322.","journal-title":"Mol Biol Rep"},{"key":"4223_CR32","unstructured":"Cockerill FR. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. (No Title). 2012."},{"issue":"10","key":"4223_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/pharmaceutics11100527","volume":"11","author":"F Rancan","year":"2019","unstructured":"Rancan F, Contardi M, Jurisch J, Blume-Peytavi U, Vogt A, Bayer IS, et al. Evaluation of drug delivery and efficacy of ciprofloxacin-loaded Povidone foils and nanofiber Mats in a wound-infection model based on ex vivo human skin. Pharmaceutics. 2019;11(10):527.","journal-title":"Pharmaceutics"},{"issue":"2","key":"4223_CR34","first-page":"341","volume":"50","author":"F Davarzani","year":"2021","unstructured":"Davarzani F, Saidi N, Besharati S, Saderi H, Rasooli I, Owlia P. Evaluation of antibiotic resistance pattern, alginate and biofilm production in clinical isolates of Pseudomonas aeruginosa. Iran J Public Health. 2021;50(2):341.","journal-title":"Iran J Public Health"},{"issue":"1","key":"4223_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40543-022-00358-x","volume":"13","author":"C Ajish","year":"2022","unstructured":"Ajish C, Kumar SD, Kim EY, Yang S, Shin SY. A short novel antimicrobial peptide BP100-W with antimicrobial, antibiofilm and anti-inflammatory activities designed by replacement with Tryptophan. J Anal Sci Technol. 2022;13(1):46.","journal-title":"J Anal Sci Technol"},{"issue":"1","key":"4223_CR36","first-page":"1936165","volume":"2022","author":"B Ndezo Bisso","year":"2022","unstructured":"Ndezo Bisso B, Tokam Kuat\u00e9 CR, Boulens N, All\u00e9mann E, Delie F, Dzoyem JP. Antibiofilm synergistic activity of streptomycin in combination with Thymol-Loaded Poly (Lactic\u2010co\u2010glycolic Acid) nanoparticles against Klebsiella pneumoniae isolates. Evidence\u2010Based Complement Altern Med. 2022;2022(1):1936165.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"issue":"7","key":"4223_CR37","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/jac\/dky087","volume":"73","author":"G Dall","year":"2018","unstructured":"Dall G, Tsang SJ, Gwynne P, MacKenzie S, Simpson A, Breusch S, et al. Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms. J Antimicrob Chemother. 2018;73(7):1830\u201340.","journal-title":"J Antimicrob Chemother"},{"key":"4223_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-019-0106-0","volume":"21","author":"L Thieme","year":"2019","unstructured":"Thieme L, Hartung A, Tramm K, Klinger-Strobel M, Jandt KD, Makarewicz O, et al. MBEC versus MBIC: the lack of differentiation between biofilm reducing and inhibitory effects as a current problem in biofilm methodology. Biol Procedures Online. 2019;21:1\u20135.","journal-title":"Biol Procedures Online"},{"issue":"6","key":"4223_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7150\/ijbs.6.556","volume":"6","author":"P Jayaraman","year":"2010","unstructured":"Jayaraman P, Sakharkar MK, Lim CS, Tang TH, Sakharkar KR. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci. 2010;6(6):556.","journal-title":"Int J Biol Sci"},{"key":"4223_CR40","unstructured":"Isenberg HD. Clinical microbiology procedures handbook. (No Title). 2004."},{"key":"4223_CR41","doi-asserted-by":"publisher","first-page":"101543","DOI":"10.1016\/j.mex.2021.101543","volume":"8","author":"P Bellio","year":"2021","unstructured":"Bellio P, Fagnani L, Nazzicone L, Celenza G. New and simplified method for drug combination studies by checkerboard assay. MethodsX. 2021;8:101543.","journal-title":"MethodsX"},{"issue":"4","key":"4223_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/antibiotics14040367","volume":"14","author":"M Moradi","year":"2025","unstructured":"Moradi M, Montazeri EA, Rafiei Asl S, Pormohammad A, Farshadzadeh Z, Dayer D, et al. In vitro and in vivo antibacterial and antibiofilm activity of zinc sulfate (ZnSO4) and carvacrol (CV) alone and in combination with antibiotics against Pseudomonas aeruginosa. Antibiotics. 2025;14(4):367.","journal-title":"Antibiotics"},{"key":"4223_CR43","unstructured":"Lorian V. Antibiotics in laboratory medicine. Lippincott Williams & Wilkins; 2005."},{"issue":"4","key":"4223_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582\u2013610.","journal-title":"Clin Microbiol Rev"},{"key":"4223_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fmicb.2016.01223","volume":"7","author":"Y Morita","year":"2016","unstructured":"Morita Y, Nakashima K-i, Nishino K, Kotani K, Tomida J, Inoue M, et al. Berberine is a novel type efflux inhibitor which attenuates the MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa. Front Microbiol. 2016;7:1223.","journal-title":"Front Microbiol"},{"issue":"1","key":"4223_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s44259-023-00013-4","volume":"1","author":"LG Kavanaugh","year":"2023","unstructured":"Kavanaugh LG, Mahoney AR, Dey D, Wuest WM, Conn GL. Di-berberine conjugates as chemical probes of Pseudomonas aeruginosa MexXY-OprM efflux function and Inhibition. Npj Antimicrobials Resist. 2023;1(1):12.","journal-title":"Npj Antimicrobials Resist"},{"issue":"10","key":"4223_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ja.2016.15","volume":"69","author":"X-Y Zhou","year":"2016","unstructured":"Zhou X-Y, Ye X-G, He L-T, Zhang S-R, Wang R-L, Zhou J, et al. In vitro characterization and Inhibition of the interaction between Ciprofloxacin and Berberine against multidrug-resistant Klebsiella pneumonia e. J Antibiot. 2016;69(10):741\u20136.","journal-title":"J Antibiot"},{"issue":"1","key":"4223_CR48","first-page":"2","volume":"9","author":"SS Aghayan","year":"2017","unstructured":"Aghayan SS, Mogadam HK, Fazli M, Darban-Sarokhalil D, Khoramrooz SS, Jabalameli F, et al. The effects of Berberine and palmatine on efflux pumps Inhibition with different gene patterns in Pseudomonas aeruginosa isolated from burn infections. Avicenna J Med Biotechnol. 2017;9(1):2.","journal-title":"Avicenna J Med Biotechnol"},{"key":"4223_CR49","doi-asserted-by":"publisher","first-page":"106774","DOI":"10.1016\/j.micpath.2024.106774","volume":"193","author":"Q Liu","year":"2024","unstructured":"Liu Q, Tang Y, Jiang S, Yu X, Zhu H, Xie X, et al. Mechanisms of action of Berberine hydrochloride in planktonic cells and biofilms of Pseudomonas aeruginosa. Microb Pathog. 2024;193:106774.","journal-title":"Microb Pathog"},{"key":"4223_CR50","doi-asserted-by":"publisher","first-page":"660431","DOI":"10.3389\/fcimb.2021.660431","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Song Y, Wang L, Kang G, Wang P, Yin H, et al. A potential combination therapy of Berberine hydrochloride with antibiotics against multidrug-resistant Acinetobacter baumannii. Front Cell Infect Microbiol. 2021;11:660431.","journal-title":"Front Cell Infect Microbiol"},{"issue":"24","key":"4223_CR51","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","volume":"23","author":"AB Lorusso","year":"2022","unstructured":"Lorusso AB, Carrara JA, Barroso CDN, Tuon FF, Faoro H. Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa. Int J Mol Sci. 2022;23(24):15779.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4223_CR52","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/microorganisms11092211","volume":"11","author":"RL Co\u0219eriu","year":"2023","unstructured":"Co\u0219eriu RL, Mare AD, Toma F, Vintil\u0103 C, Ciurea CN, Tog\u0103nel RO, et al. Uncovering the resistance mechanisms in extended-drug-resistant pseudomonas aeruginosa clinical isolates: insights from gene expression and phenotypic tests. Microorganisms. 2023;11(9):2211.","journal-title":"Microorganisms"},{"issue":"2","key":"4223_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1556\/1886.2024.00035","volume":"14","author":"TJ Hossain","year":"2024","unstructured":"Hossain TJ. Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations. Eur J Microbiol Immunol. 2024;14(2):97\u2013115.","journal-title":"Eur J Microbiol Immunol"},{"issue":"2","key":"4223_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/ecp.13.6","volume":"6","author":"A Trivedi","year":"2013","unstructured":"Trivedi A, Lee RE, Meibohm B. Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives. Expert Rev Clin Pharmacol. 2013;6(2):159\u201370.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"22","key":"4223_CR55","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","volume":"21","author":"MTT Thi","year":"2020","unstructured":"Thi MTT, Wibowo D, Rehm BH. Pseudomonas aeruginosa biofilms. Int J Mol Sci. 2020;21(22):8671.","journal-title":"Int J Mol Sci"},{"key":"4223_CR56","doi-asserted-by":"crossref","unstructured":"Zhou H, Wang W, Cai L, Yang T. Potentiation and mechanism of Berberine as an antibiotic adjuvant against multidrug-resistant bacteria. Infect Drug Resist. 2023:7313\u201326.","DOI":"10.2147\/IDR.S431256"},{"issue":"4","key":"4223_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/antibiotics10040414","volume":"10","author":"D Kart","year":"2021","unstructured":"Kart D, Re\u00e7ber T, Nemutlu E, Sagiroglu M. Sub-inhibitory concentrations of Ciprofloxacin alone and combinations with plant-derived compounds against P. aeruginosa biofilms and their effects on the metabolomic profile of P. aeruginosa biofilms. Antibiotics. 2021;10(4):414.","journal-title":"Antibiotics"},{"issue":"4","key":"4223_CR58","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1159\/000479411","volume":"42","author":"Y Li","year":"2017","unstructured":"Li Y, Huang J, Li L, Liu L. Synergistic activity of Berberine with Azithromycin against Pseudomonas aeruginosa isolated from patients with cystic fibrosis of lung in vitro and in vivo. Cell Physiol Biochem. 2017;42(4):1657\u201369.","journal-title":"Cell Physiol Biochem"},{"key":"4223_CR59","doi-asserted-by":"publisher","first-page":"104674","DOI":"10.1016\/j.amsu.2022.104674","volume":"82","author":"TSU Sihotang","year":"2022","unstructured":"Sihotang TSU, Widodo ADW, Endraswari PD. Effect of ciprofloxacin, levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: a case control study with time kill curve analysis. Annals Med Surg. 2022;82:104674.","journal-title":"Annals Med Surg"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04223-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04223-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04223-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:40:07Z","timestamp":1757346007000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04223-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04223-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the guidelines and regulations of Ahvaz Jundishapur University of Medical Sciences and approved by the institutional ethical committees (Ethical code: IR.AJUMS.ABHC.REC.1402.082).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}